研究者
J-GLOBAL ID:201801008135094969
更新日: 2024年03月02日
並川 健二郎
ナミカワ ケンジロウ | KENJIRO NAMIKAWA
所属機関・部署:
職名:
医長
論文 (114件):
-
Naohito Hatta, Dai Ogata, Jun Asai, Takeo Maekawa, Takamichi Ito, Tatsuya Takenouchi, Yukiko Kiniwa, Azusa Miyashita, Takuya Miyagawa, Ikko Muto, et al. Recent treatment and prognosis in 643 patients with extramammary Paget's disease. Experimental dermatology. 2024. 33. 2. e15030
-
Shogo Wada, Eiji Nakano, Miho Nakajima, Satsuki Kishikawa, Akihiko Yoshida, Taisuke Mori, Atsuyoshi Osada, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki. Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly. The Journal of dermatology. 2024
-
Yuuki Nishimura, Eijitsu Ryo, Satoshi Inoue, Masahito Kawazu, Toshihide Ueno, Kenjiro Namikawa, Akira Takahashi, Dai Ogata, Akihiko Yoshida, Naoya Yamazaki, et al. Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics. JID innovations : skin science from molecules to population health. 2023. 3. 6. 100229-100229
-
Shogo Wada, Tomone Watanabe, Taisuke Ishii, Yuichi Ichinose, Ryoko Rikitake, Dai Ogata, Eiji Nakano, Kenjiro Namikawa, Naoya Yamazaki, Takahiro Higashi. A retrospective study of sentinel lymph node biopsy for skin cancer in Japan: Comparison with breast cancer and evaluation of factors related to its use. Cancer medicine. 2023
-
Kenjiro Namikawa, Takamichi Ito, Shusuke Yoshikawa, Koji Yoshino, Yukiko Kiniwa, Shuichi Ohe, Taiki Isei, Tatsuya Takenouchi, Hiroshi Kato, Satoru Mizuhashi, et al. Systemic therapy for Asian patients with advanced BRAF V600-mutant melanoma in a real-world setting: A multi-center retrospective study in Japan (B-CHECK-RWD study). Cancer medicine. 2023
もっと見る
MISC (18件):
-
Aya Maekawa, Atsushi Tanemura, Kyoko Tonomura, Yukinobu Nakagawa, Eiji Kiyohara, Mari Wataya-Kaneda, Kenjiro Namikawa, Naoya Yamazaki, Manabu Fujimoto. A case of malignant melanoma with shrinking metastases after sequential severe irAEs. Journal of Cutaneous Immunology and Allergy. 2020. 3. 2. 50-51
-
中村 泰大, 浅井 純, 井垣 浩, 猪爪 隆史, 並川 健二郎, 林 礼人, 福島 聡, 藤村 卓, 伊東 孝通, 今福 惠輔, et al. 日本皮膚科学会ガイドライン 皮膚悪性腫瘍ガイドライン第3版 メラノーマ診療ガイドライン2019. 日本皮膚科学会雑誌. 2019. 129. 9. 1759-1843
-
Yasuhiro Nakamura, Kenjiro Namikawa, Koji Yoshino, Shusuke Yoshikawa, Hiroshi Uchi, Katsunobu Goto, Yoshiyuki Nakamura, Satoshi Fukushima, Yukiko Kiniwa, Tatsuya Takenouchi, et al. Real-world efficacy of anti-PD-1 antibodies in advanced acral melanoma patients: A retrospective, multicenter study (JAMP study). JOURNAL OF CLINICAL ONCOLOGY. 2019. 37. 15
-
Kenjiro Namikawa. Update on treatment strategy for patients with BRAF-mutated melanoma. ANNALS OF ONCOLOGY. 2016. 27
-
N. Yamazaki, H. Uhara, S. Fukushima, H. Uchi, N. Shibagaki, Y. Kiyohara, A. Tsutsumida, K. Namikawa, R. Okuyama, Y. Otsuka, et al. Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma. Cancer Chemotherapy and Pharmacology. 2015. 76. 5. 969-975
もっと見る
前のページに戻る